<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Neurosci</journal-id><journal-title>BMC Neuroscience</journal-title><issn pub-type="epub">1471-2202</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2202-6-27</article-id><article-id pub-id-type="pmid">15826318</article-id><article-id pub-id-type="doi">10.1186/1471-2202-6-27</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The neuronal ceroid lipofuscinosis <italic>Cln8 </italic>gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Lonka</surname><given-names>Liina</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>liina.lonka@helsinki.fi</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Aalto</surname><given-names>Antti</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>antti.aalto@helsinki.fi</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Kopra</surname><given-names>Outi</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I4">4</xref><email>outi.kopra@ktl.fi</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Kuronen</surname><given-names>Mervi</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>mervi.kuronen@helsinki.fi</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Kokaia</surname><given-names>Zaal</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>zaal.kokaia@neurol.lu.se</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Saarma</surname><given-names>Mart</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>mart.saarma@helsinki.fi</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Lehesjoki</surname><given-names>Anna-Elina</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>anna-elina.lehesjoki@helsinki.fi</email></contrib></contrib-group><aff id="I1"><label>1</label>Neuroscience Center, University of Helsinki, Finland</aff><aff id="I2"><label>2</label>Folkh&#x000e4;lsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Finland</aff><aff id="I3"><label>3</label>Institute of Biotechnology, University of Helsinki, Finland</aff><aff id="I4"><label>4</label>National Public Health Institute, Finland</aff><aff id="I5"><label>5</label>Laboratory of Neural Stem Cell Biology, Section of Restorative Neurology, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, University Hospital, Lund, Sweden</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>13</day><month>4</month><year>2005</year></pub-date><volume>6</volume><fpage>27</fpage><lpage>27</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2202/6/27"/><history><date date-type="received"><day>29</day><month>9</month><year>2004</year></date><date date-type="accepted"><day>13</day><month>4</month><year>2005</year></date></history><copyright-statement>Copyright &#x000a9; 2005 Lonka et al; licensee BioMed Central Ltd.</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license><abstract><sec><title>Background</title><p>The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative disorders characterized by accumulation of autofluorescent material in many tissues, especially in neurons. Mutations in the <italic>CLN8 </italic>gene, encoding an endoplasmic reticulum (ER) transmembrane protein of unknown function, underlie NCL phenotypes in humans and mice. The human phenotype is characterized by epilepsy, progressive psychomotor deterioration and visual loss, while motor neuron degeneration (<italic>mnd</italic>) mice with a <italic>Cln8 </italic>mutation show progressive motor neuron dysfunction and retinal degeneration.</p></sec><sec><title>Results</title><p>We investigated spatial and temporal expression of <italic>Cln8 </italic>messenger ribonucleic acid (mRNA) using <italic>in situ </italic>hybridization, reverse transcriptase polymerase chain reaction (RT-PCR) and northern blotting. <italic>Cln8 </italic>is ubiquitously expressed at low levels in embryonic and adult tissues. In prenatal embryos <italic>Cln8 </italic>is most prominently expressed in the developing gastrointestinal tract, dorsal root ganglia (DRG) and brain. In postnatal brain the highest expression is in the cortex and hippocampus. Expression of <italic>Cln8 </italic>mRNA in the central nervous system (CNS) was also analyzed in the hippocampal electrical kindling model of epilepsy, in which <italic>Cln8 </italic>expression was rapidly up-regulated in hippocampal pyramidal and granular neurons.</p></sec><sec><title>Conclusion</title><p>Expression of <italic>Cln8 </italic>in the developing and mature brain suggests roles for Cln8 in maturation, differentiation and supporting the survival of different neuronal populations. The relevance of <italic>Cln8 </italic>up-regulation in hippocampal neurons of kindled mice should be further explored.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The neuronal ceroid lipofuscinoses (NCLs) comprise a group of human neurodegenerative disorders (CLN1-CLN8) characterized by epilepsy, visual failure, psychomotor deterioration and accumulation of autofluorescent lipopigment in many tissues, especially in neurons [<xref ref-type="bibr" rid="B1">1</xref>]. Six genes underlying human NCLs have been identified and the proteins initially characterized (reviewed in [<xref ref-type="bibr" rid="B2">2</xref>]). Naturally occurring mouse models exist for CLN6 and CLN8 [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>], while mouse models for CLN1, CLN2 and CLN3 have been generated by gene targeting [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B10">10</xref>].</p><p>The ubiquitously expressed <italic>CLN8 </italic>gene encodes a transmembrane protein which localizes to the ER and the ER-Golgi intermediate compartment in non-neuronal cells and to the ER in neuronal cells [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. Mutations in <italic>CLN8 </italic>result in two distinct NCL phenotypes in humans: Northern epilepsy (Progressive epilepsy with mental retardation, EPMR, OMIM 600143) described in Finnish patients, and variant late infantile onset NCL in a subset of Turkish patients [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. EPMR is characterized by frequent drug-resistant epileptic seizures with onset at 5&#x02013;10 years of age, followed by progressive mental retardation [<xref ref-type="bibr" rid="B14">14</xref>], while the Turkish patients show earlier onset and a more rapid progression [<xref ref-type="bibr" rid="B15">15</xref>]. In EPMR, intracellular storage material, including subunit c of the mitochonrdial ATP synthase as the main protein component, is most prominent in the CNS, especially in the third layer of the isocortex and hippocampal regions CA2-4 [<xref ref-type="bibr" rid="B16">16</xref>]. In the cerebral isocortex the pyramidal cells of the deeper parts of lamina III are severely ballooned, and hippocampal region CA2 shows neuronal loss and neuronophagy [<xref ref-type="bibr" rid="B16">16</xref>]. A frameshift mutation in mouse <italic>Cln8 </italic>that predicts a truncated protein underlies the phenotype of the <italic>mnd </italic>mouse, a naturally occuring NCL mouse model [<xref ref-type="bibr" rid="B4">4</xref>]. Contrary to human patients, epilepsy is not a prominent feature in <italic>mnd</italic>, which is characterized by progressive motor neuron dysfunction and retinal degeneration [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. The brain appears to remain relatively intact [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Accumulation of subunit c of the mitochondrial ATP synthase, neurofilament redistribution in spinal motor neurons and accumulation of ubiquitin deposits are characteristic for <italic>mnd </italic>[<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>].</p><p>Here we characterized the spatial and temporal expression of <italic>Cln8 </italic>mRNA in mice. Moreover, as epilepsy is the dominant phenotype in human patients, we investigated the CNS expression of <italic>Cln8 </italic>mRNA in the hippocampal electrical kindling model of epilepsy in which repeated electrical stimulations trigger a progressive intensification of epileptiform responses, and kindled mice retain abnormal excitability thereafter [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>].</p></sec><sec><title>Results</title><sec><title>The <italic>Cln8 </italic>gene is ubiquitously expressed in mouse tissues</title><p>The expression of the <italic>Cln8 </italic>gene in mouse tissues was first analyzed by northern blot and real-time quantitative RT-PCR analyses. In northern blot analysis one ~3 kilobase (kb) <italic>Cln8 </italic>specific transcript was detected in all tissues analyzed including a 14-day embryo (E14) (Fig. <xref ref-type="fig" rid="F1">1A</xref>). In addition, one ~7 kb transcript was seen in all tissues except testis and heart (Fig. <xref ref-type="fig" rid="F1">1A</xref>). In spleen, an additional transcript of ~2 kb was detected (Fig. <xref ref-type="fig" rid="F1">1A</xref>). The ~7 kb and ~2 kb transcripts were notably weaker than the ~3 kb transcript. RT-PCR analysis covering the 867 bp open reading frame of <italic>Cln8 </italic>resulted in a single fragment of the same size in 12 different mouse tissues (data not shown), suggesting that the different transcripts detected in the northern analysis are not due to alternative splicing in the coding region.</p><p>We then estimated the level of <italic>Cln8 </italic>expression using real-time quantitative RT-PCR analysis. <italic>Cln8 </italic>showed highest expression in liver, spleen, heart and skeletal muscle, 2.5, 2.2, 1.7 and 1.6 fold higher (respectively) than in the brain (Fig. <xref ref-type="fig" rid="F1">1B</xref>). Expression was lowest in 11-day embryo and adult kidney, lung and testis, 0.6, 0.9, 0.5 and 0.03 fold lower than in the brain (Fig. <xref ref-type="fig" rid="F1">1B</xref>). This indicates that <italic>Cln8 </italic>expression levels in adult mouse tissues as well as in whole mouse embryos are not dramatically different.</p></sec><sec><title><italic>Cln8 </italic>is expressed throughout mouse development</title><p>The tissue expression of <italic>Cln8 </italic>during development and brain maturation was characterized using radioactive mRNA <italic>in situ </italic>hybridization analysis. For this purpose, whole embryo sections from E13, E15.5 and E17 mice and brain sections from postnatal (P) P0, P5, P10 and adult mice were used and the expression of <italic>Cln8 </italic>was quantitated by a computer based MCID image analysis system.</p><p>In fresh-frozen E13 and E17 embryos the overall expression of <italic>Cln8 </italic>was weak. In E17 the most prominent expression was detected in the developing gastrointestinal tract (Fig. <xref ref-type="fig" rid="F2">2A, 2B</xref>). In addition, there was high expression in the DRG neurons (Fig. <xref ref-type="fig" rid="F2">2C, 2D</xref>). Some <italic>Cln8</italic>-specific signal was also detected in the developing brain (Fig. <xref ref-type="fig" rid="F2">2E</xref>). The expression of <italic>Cln8 </italic>in E13 was similar to that in E17 except in the DRG neurons, where no signal was detected (data not shown). In paraffin-embedded E15.5 embryos a <italic>Cln8</italic>-specific signal was detected in the developing gastrointestinal tract, adrenal glands and the developing brain, especially in the cortical plate (data not shown).</p><p>In postnatal mice (P0, P5, P10 and adult) <italic>Cln8 </italic>expression was quantitated in the cortex, cerebellum and different hippocampal regions. Expression at P0 was low but specific in hippocampal regions CA1, CA3 and the granular cell layer of the dentate gyrus and in the cortex (Fig. <xref ref-type="fig" rid="F3">3</xref>). At P5 and P10, the <italic>Cln8 </italic>expression increased in the hippocampal CA1 region (to 115% and 106% of P0) and especially in the CA3 region (to 139% of P0) (Fig. <xref ref-type="fig" rid="F3">3</xref>). In adult brain the expression levels of <italic>Cln8 </italic>were lower than at P0, P5 and P10 in every region analyzed (Fig. <xref ref-type="fig" rid="F3">3</xref>). When compared with adults, a statistically significant difference in <italic>Cln8 </italic>expression was detected in the cortex at P0, P5 and P10 and in the CA3 region at P10 (Fig. <xref ref-type="fig" rid="F3">3</xref>). Expression of <italic>Cln8 </italic>in adult cerebellum was 156% of expression in the cortex (data not shown). In all maturation stages, the expression of <italic>Cln8 </italic>was highest in hippocampal region CA3 (Fig. <xref ref-type="fig" rid="F3">3</xref>).</p></sec><sec><title><italic>Cln8 </italic>expression is strongly up-regulated in the hippocampal electrical kindling model of epilepsy</title><p>Epileptic seizures are a characteristic feature in human patients with <italic>CLN8 </italic>mutations. We therefore analyzed, by mRNA <italic>in situ </italic>hybridization analysis, possible changes in <italic>Cln8 </italic>expression 2 h, 6 h and 24 h after kindling-induced epileptic seizures. Animals were subjected to 40 rapid kindling stimulations which lead to increased excitability in mice at 4 weeks after the stimulation [<xref ref-type="bibr" rid="B25">25</xref>]. Each rapid kindling stimulation induced relatively short focal (grade 0&#x02013;2) or long-lasting generalized (grade 4&#x02013;5) seizures. The mean duration of afterdischarges was 20 &#x000b1; 3 s for focal seizures and 76 &#x000b1; 8 s for generalized seizures. All animals experienced multiple (11 &#x000b1; 2) grade 4&#x02013;5 generalized tonic-clonic seizures. The expression of <italic>Cln8 </italic>in the control, electrode implanted but non-stimulated mice (0 h; Fig. <xref ref-type="fig" rid="F4">4</xref>) was essentially identical to that in wild-type adult mouse brain (Fig. <xref ref-type="fig" rid="F3">3</xref>). After kindling stimulations <italic>Cln8 </italic>was strongly up-regulated in the hippocampus, especially in the CA3 region and most prominently in the granular cell layer of the detate gyrus (Fig. <xref ref-type="fig" rid="F4">4</xref>). After 2 h, 6 h and 24 h expression of <italic>Cln8 </italic>in CA3 was 92%, 114% and 134% of that of controls, and in the granular cell layer of the dentate gyrus 128%, 225% and 286% of controls, respectively (Fig. <xref ref-type="fig" rid="F4">4</xref>). When compared to controls, a statistically significant increase in <italic>Cln8 </italic>expression was detected in the cortex after 6 h, and in the CA1 and CA3 regions, and the granular cell layer of the dentate gyrus after 2 h, 6 h and 24 h (Fig. <xref ref-type="fig" rid="F4">4</xref>). All changes in <italic>Cln8 </italic>mRNA expression after rapid kindling stimulations were bilateral with no differences between the sides.</p></sec></sec><sec><title>Discussion</title><p>We analyzed the expression of the <italic>Cln8 </italic>gene during mouse development and in the hippocampal kindling model of epilepsy to gain understanding of the role of CLN8 in the disease mechanisms underlying both human and mouse NCLs. In northern blot analysis a <italic>Cln8 </italic>transcript of approximately 3 kb was detected in all tissues studied. Two additional transcripts, approximately 2 kb and 7 kb, were detected in several tissues. Thus, <italic>Cln8 </italic>expression resembles that of human <italic>CLN8</italic>, which is ubiquitously expressed with transcripts of 1.4 kb, 3.4 kb and 7.5 kb [<xref ref-type="bibr" rid="B4">4</xref>]. The open reading frame of mouse <italic>Cln8 </italic>is 82% identical with <italic>CLN8 </italic>and at the amino acid level the proteins are 85% identical [<xref ref-type="bibr" rid="B4">4</xref>]. In both human and mouse genes the RT-PCR analysis of the <italic>CLN8 </italic>open reading frame resulted in a single fragment, suggesting that the different size transcripts seen in northern analysis are due to alternative 3' untranslated regions as previously suggested for the human <italic>CLN8 </italic>gene [<xref ref-type="bibr" rid="B4">4</xref>]. It is, however, also possible that the <italic>CLN8</italic>/<italic>Cln8 </italic>genes have several transcription initiation sites. Real-time quantitative RT-PCR analysis further suggested that the expression levels of <italic>Cln8 </italic>are relatively low in both adult and embryonic tissues, and showed that expression levels in various tissues do not differ dramatically. The remarkably low expression of <italic>Cln8 </italic>in testis could reflect a high level of the control gene analyzed in this tissue. Despite ubiquitous expression of the underlying gene and accumulation of storage material in all tissues, the most severe damage in EPMR patients and <italic>mnd </italic>mice is in neuronal cells. This is also characteristic of other NCLs, suggesting that NCL proteins may have a specific function in neuronal cells distinct from the role in non-neuronal cells, or that certain neuronal populations may be more sensitive to the disturbed function of NCL proteins.</p><p><italic>In situ </italic>hybridization analysis of developing mice indicates that <italic>Cln8 </italic>mRNA is expressed throughout development as well as in the mature brain. The expression of <italic>Cln8 </italic>in embryonic stages E13 and E17 was specific but low in many tissues including brain, but remarkably high in the developing gastrointestinal tract. This may indicate a role for <italic>Cln8 </italic>in the innervation of the developing gut. In addition, in the E17 embryo <italic>Cln8 </italic>expression was high in DRG neurons. These neurons determine the connections between interneurons and motoneurons of the spinal cord. Assuming a role for Cln8 in this process, its disturbed function might result in defective connections in DRG with consecutive dysfunction of motor neurons resulting in progressive paralysis in the <italic>mnd </italic>mouse model [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. The expression of <italic>Cln8 </italic>in postnatal mouse brain was highest at developmental stages P5 and P10, especially in hippocampal region CA3. The brain expression was clearly lower in adult mice than at P0, P5 and P10, suggesting a role for Cln8 in brain maturation. This early postnatal period is characterized by a rapid increase in the number of synapses, as well as maturation of oligodendrocytes, the myelin-forming cells in the CNS [<xref ref-type="bibr" rid="B26">26</xref>]. Two other NCL proteins, Ppt1 and Cln3, have been localized to synaptic areas of neurons [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>] suggesting the importance of these NCL proteins for synaptic functions. However, detailed study of the function of Cln8 in the CNS and different brain cells is currently hampered by the lack of a specific antibody detecting endogenous Cln8. Very low levels of <italic>Cln8 </italic>mRNA were also detected in developing and adult motoneurons and retina (data not shown). However, the <italic>Cln8 </italic>transcript levels in these samples were virtually indistinguishable from the respective sense controls.</p><p>The expression of several other NCL genes in mouse and/or rat has been characterized. In addition to <italic>Cln8, Cln1 </italic>and <italic>Cln5 </italic>also show developmental regulation, whereas the expression of two other NCL genes, <italic>cathepsin D </italic>underlying a naturally occuring sheep NCL model and <italic>Cln2 </italic>underlying a human late infantile-onset NCL form, is relatively constant in the rat brain during development [<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B32">32</xref>]. Mouse <italic>Cln3 </italic>is expressed in adult mice throughout the brain, and in the hippocampus the most prominent expression is detected in the granular cell layer of the dentate gyrus and pyramidal cells [<xref ref-type="bibr" rid="B28">28</xref>]. In addition, human <italic>CLN1 </italic>and <italic>CLN5 </italic>genes are expressed at the beginning of neurogenesis in embryonic human brains [<xref ref-type="bibr" rid="B33">33</xref>]. This expression increases as brain development proceeds. Expression of NCL genes, including <italic>Cln8</italic>, in the developing and mature brain indicates that NCL proteins may have roles not only in supporting the survival of neurons but also in the maturation and differentiation of different neuronal populations during development. Defects in maturation processes could potentially lead to neuronal degeneration and loss of neurons.</p><p>In the kindling model of experimental epilepsy a rapid up-regulation of <italic>Cln8 </italic>expression was detected in the brain, especially in hippocampal regions CA3 and the granular cell layer of the dentate gyrus. The expression of <italic>Cln8 </italic>increased at every time point measured, and was highest 24 h after kindling. Whether single or focal seizures alone are sufficient to induce <italic>Cln8 </italic>expression requires further investigation. While only <italic>Cln8 </italic>expression has been investigated in the kindling model, expression of <italic>cathepsin D </italic>and the <italic>Cln1 </italic>encoded palmitoyl protein thioesterase 1 (Ppt1) protein has been studied using kainic acid-induced seizures in rats as a model. Both show increased expression in this model, <italic>cathepsin D </italic>in the hippocampus, limbic cortex and temporo-parieto-occipital neocortex [<xref ref-type="bibr" rid="B34">34</xref>] and the Ppt1 protein most prominently in pyramidal cells of hippocampal regions CA1 and CA3 [<xref ref-type="bibr" rid="B35">35</xref>]. Although different forms of NCLs are genetically heterogenous, they share a common hippocampal pathology, which is distinct from lesions caused by anoxic-ischemic events and is instead suggested to be a consequence of primary metabolic defects [<xref ref-type="bibr" rid="B36">36</xref>]. Increased plasma glutamate levels, decreased glutamate uptake, descreased glutamate transporters as well as changes in ionotropic glutamate receptors has been described in <italic>mnd </italic>mice [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. Also, prominent loss of GABAergic interneurons in <italic>mnd </italic>as well as in the <italic>Cln1 </italic>and <italic>Cln3 </italic>knock-out mice has been reported [<xref ref-type="bibr" rid="B39">39</xref>-<xref ref-type="bibr" rid="B41">41</xref>]. Alterations in both glutamatergic and GABAergic neurotransmission may both contribute to chronic excitotoxicity, hypothesized to underlie the cellular dysfunction and brain pathology in NCL disorders [<xref ref-type="bibr" rid="B42">42</xref>].</p></sec><sec><title>Conclusion</title><p>The <italic>Cln8 </italic>gene is widely expressed in embryonic and adult mouse tissues. In line with this, and comparable with other NCL disorders, accumulation of storage deposits in CLN8-associated disorders occurs in all tissues. However, as the most striking accumulation and cellular dysfunction is limited to neurons, it is likely that CLN8/Cln8 is involved in a neuron-specific biochemical pathway or that neuronal cells are more sensitive to accumulating material or lack compensatory pathways.</p><p>The <italic>Cln8 </italic>gene is expressed throughout brain development and also in mature brain, suggesting a role for Cln8 in maturation and differentiation of neurons and in supporting the survival of neurons. The expression of <italic>Cln8 </italic>showed regional differences, suggesting a specific function for Cln8 in specific neuronal populations. The relevance of <italic>Cln8 </italic>up-regulation in hippocampal neurons of kindled mice needs to be studied further.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Northern blot analysis</title><p>FirstChoice&#x02122; Northern Blot Mouse Blot I (Ambion, Austin, TX, USA) was used to analyze the distribution of <italic>Cln8 </italic>expression in various tissues. An 872 base pair (bp) deoxyribonucleic acid (DNA) fragment including a <italic>Cln8 </italic>open reading frame of 867 bp, digested from the SvPoly-<italic>Cln8 </italic>expression vector with restriction enzyme <italic>Bam</italic>HI, was used as a probe. The hybridization was performed according to the manufacturer's instructions with Ultra sensitive Hybridization buffer (Ambion), and salmon sperm DNA and Cot-1 DNA for blocking.</p></sec><sec><title>Real-time quantitative RT-PCR analysis of <italic>Cln8</italic></title><p>Real-time quantitative RT-PCR analysis of <italic>Cln8 </italic>was performed in an ABI PRISM<sup>&#x000ae; </sup>7000 SDS thermal cycler (Applied Biosystems, Foster City, CA, USA) using 5 &#x003bc;l of each tissue from Mouse Multiple Tissue cDNA (MTC&#x02122;) Panel II (BD Biosciences) as template. Each 25 &#x003bc;l reaction contained 300 nM of reverse primer 5'-CCACTGGTTGGCCTTCCA-3' and 900 nM of forward primer 5'-GCCCTTCACCTGCATTTCC-3' as well as 200 nM of <italic>Cln8 </italic>specific probe 6FAM-TGACCACCCAGCCTTCAGGAGCAT-TAMRA in TaqMan<sup>&#x000ae; </sup>Universal PCR Master Mix (Applied Biosystems). The primers were optimized for analysis and the PCR fragment of 76 bp covered the region from 510 to 585 bp of the <italic>Cln8 </italic>open reading frame (GenBank sequence accession no AF125307). The <italic>Cln8 </italic>specific probe included a reporter dye 6-carboxyfluorescein (FAM) and a quencher dye 6-carboxy-tetramethyl-rhodamine (TAMRA). Endogenous control reactions were performed using Assays-on-Demand Mm00446973_m1 TATA-box binding protein amplification according to the manufacturer's instructions (Applied Biosystems). Each reaction was performed in triplicate. Standard complementary DNA (cDNA) solutions, generated from C57/BL mice cortex mRNA, and standard curve method were used (User Bulletin #2: ABI PRISM(R) 7700 Sequence Detection System. P/N 4303859B (2001) Applied Biosystems. 36 s.). Statistical analyses were performed using Microsoft Excel.</p><p>The DNA fragment covering the whole open reading frame of <italic>Cln8 </italic>was PCR amplified using primers 3'-GTGATTTCTCCGGTGCTAGG-5' and 3'-GCAACCACCATTTCTCAGGT-5'.</p></sec><sec><title><italic>In situ </italic>hybridization</title><p>Paraffin and cryosections of NMRI or C57/BL mice were prepared and analyzed by mRNA <italic>in situ </italic>hybridization as previously described [<xref ref-type="bibr" rid="B43">43</xref>-<xref ref-type="bibr" rid="B45">45</xref>] with slight modifications. The isolated tissues from postnatal wild-type and kindling mice were fresh-frozen and sectioned. Embryos were either fixed in 4% paraformaldehyde and embedded in paraffin or fresh-frozen and sectioned. For all serial sections of 8&#x02013;14 &#x003bc;m, a single <sup>35</sup>S-labeled 370 bp <italic>Cln8 </italic>specific complementary RNA (cRNA) probe (from bp 29 to 398; GeneBank AF125307) was used. For the generation of the antisense and control sense cRNAs, the vector (pBluescript vector; Stratagene, La Jolla, CA, USA) containing the PCR-amplified <italic>Cln8 </italic>fragment was linearized and used as a template for RNA polymerases T3 and T7, respectively, using &#x003b1;-<sup>35</sup>S-labeled UTP (Amersham Biosciences, Uppsala, Sweden).</p><p>The paraffin sections were treated as cryosections, after first being deparaffinized in xylene and rehydrated in a descending ethanol series. All the slides were fixed in 4% paraformaldehyde, rinsed twice in phosphate-buffered saline and treated with proteinase K (20 &#x003bc;g/ml for paraffin sections, 1 &#x003bc;g/ml for cryosections). Next, the slides were postfixed in 4% paraformaldehyde, and the cryosections rinsed in 50% deionized formamide in 2 &#x000d7; standard sodium citrate (SSC). After being washed in distilled water, all slides were acetylated for 10 minutes with 0.25% acetic anhydride in 0.1 M triethanolamine. The paraffin sections were then dehydrated in an ascending ethanol series, while the cryosections were rinsed again with 50% formamide in 2 &#x000d7; SSC. Prehybridization for 1 h was subsequently performed at +52&#x000b0;C with hybridization buffer containing 60% formamide, 10% dextran sulphate, 1 &#x000d7; Denhardt's solution, 0.5 mg/ml yeast transfer RNA (tRNA), and 100 mM dithiothreitol. After prehybridization, cRNA probes were added to the hybridization buffer at a concentration of 35 000 cpm/&#x003bc;l, and hybridization was carried out overnight at +52&#x000b0;C in a chamber humidified with 60% formamide and 5 &#x000d7; SSC.</p><p>After hybridization the sections were first washed in 5 &#x000d7; SSC, 10 mM dithiothreitol at +50&#x000b0;C for 30 minutes, followed by 30 minutes in 50% formamide, 2 &#x000d7; SSC, 30 mM dithiothreitol at +65&#x000b0;C, and 3 &#x000d7; 10 minutes in NTE-buffer (0.5 M NaCl, 10 mM Tris-HCl, pH 8.0, 5 mM EDTA) at +37&#x000b0;C. Next, the slides were treated with RNase A (20 &#x003bc;g/ml) in NTE-buffer at +37&#x000b0;C for 30 min and washed for 15 min in NTE-buffer at +37&#x000b0;C. Washing with 50% formamide, 2 &#x000d7; SSC, 30 mM dithiothreitol was then repeated, after which the sections were washed in 2 &#x000d7; SSC and 0.1 &#x000d7; SSC, each for 15 min at +37&#x000b0;C. The slides were dehydrated at room temperature with ethanol containing 0.3 M ammonium acetate, air-dried, and exposed to BioMax MR Film (Kodak) together with <sup>14</sup>C radioactive standards (Amersham Biosciences) for 5 days. Finally, the sections were dipped in NTB-2 emulsion (Kodak), developed after 3 to 4 weeks using D-19 developer (Kodak), fixed with Kodak Unifix, counterstained with hematoxylin (Shandon Inc./Thermoshandon, Pittsburgh, PA, USA), and mounted with Permount (Fisher Scientific International Inc., Hampton, NH, USA). Mice were bred in the Viikki Laboratory Animal Center, University of Helsinki. The experiments were conducted according to the "European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific purposes" with the approval of the institutional ethics committee.</p></sec><sec><title>Rapid kindling procedure</title><p>Adult male C57/BL mice weighing 22&#x02013;25 g (n = 16) were anaesthetized with sodium pentobarbital (60 mg/kg i.p.), and bipolar stainless steel electrodes (Plastics One) were implanted in the left ventral hippocampus using a Kopf stereotaxic frame as previously described [<xref ref-type="bibr" rid="B46">46</xref>]. One week later, the mice were electrically stimulated with forty threshold stimulations with 5 min intervals (10 Hz frequency, 1 ms square-wave pulses for 10 s). The electroencephalogram was continuously recorded during the whole rapid kindling procedure using the MacLab/4e system (ADInstruments). To determine the threshold, current intensity was increased stepwise (10 &#x003bc;A increments, starting from 10 &#x003bc;A) every 5 min until focal epileptiform activity (afterdischarge) of at least 5 s duration was elicited. Rapid kindling stimulations were then given on the same day. Behavioral convulsions were scored according to a modification [<xref ref-type="bibr" rid="B25">25</xref>] of the scale of Racine [<xref ref-type="bibr" rid="B47">47</xref>]: grade 0, arrest, normal behavior; grade 1, facial twitches; grade 2, chewing and nodding; grade 3, forelimb clonus; grade 4, rearing, body jerks, tail upholding; and grade 5, imbalance, hind-limb clonus and vocalization. At 2, 6 and 24 h after the last stimulus-evoked seizure, animals were decapitated (four animals in each group) and brains were processed for <italic>in situ </italic>hybridization. Four non-stimulated, electrode-implanted mice served as controls and were killed together with the experimental animals from different groups. The correct localization of the electrode was controlled for each animal in the coronal sections of the brain used for <italic>in situ </italic>hybridization. All experimental procedures were approved by the Research Ethics Committee at the Medical Faculty of the University of Lund.</p></sec><sec><title>Quantitative and statistical analysis</title><p>Quantification of radioactive <italic>in situ </italic>hybridization films was done by digitizing the film images with a computer-based MCID image analysis system (Imaging Research). Gray levels from <sup>14</sup>C radioactive standards were used in a third-degree polynomial calibration to obtain equivalent values of tissue radioactivity (nCi/g) for different brain regions. Measurements for each structure were carried out in several sections per animal. Since there were no significant differences between the two sides, values were pooled to obtain the mean value for each animal and brain region. Data from four control and four experimental animals for every probe and time point were used for analysis. Statistical analysis was performed using Student's t-tests. In the figures, the densities of hybridization signals of sense and antisense probes are shown separately. Sense values were not subtracted from antisense values because of different probes used. Error bars represent standard error of the mean; symbols *, ** and *** represent p &#x0003c; 0.05, 0.01 and 0.001, respectively.</p></sec></sec><sec><title>Authors' contributions</title><p>LL carried out real-time quantitative PCR and northern blot analyses. In addition, LL was involved in the analysis of mRNA <italic>in situ </italic>results and design of the study, drafted the manuscript and made the figures. AA carried out the mRNA <italic>in situ </italic>analysis and was involved in drafting the manuscript. OK prepared several mouse tissue samples for the mRNA <italic>in situ </italic>analysis, was involved in the analysis of the mRNA <italic>in situ </italic>results, and revised the manuscript. MK established the real-time quantitative RT-PCR methodology and helped with the analysis. ZK provided all kindling samples and contributed significantly to figures <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref>. mRNA <italic>in situ </italic>analyses were conducted under the supervision of MS, who also revised the manuscript and was involved in the design of the study. AEL was involved in the design of the study, analysis of the results and revision of the manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Teija-Tuulia Toivonen and Eila Kujam&#x000e4;ki for technical assistance as well as Tarja Salonen and Tarja Joensuu for advice and support. Susanna Ranta is thanked for cloning and testing constructs for the mRNA <italic>in situ </italic>hybridization analysis. Pertti Panula and Oleg Anichtch are thanked for help in the quantification analysis of mRNA <italic>in situ </italic>hybridization and Matthew Phillips and Jodie Painter for critical reading of the manuscript. This work has been supported by the Academy of Finland Centre of Excellence in Disease Genetics, project 44870 Finnish Centre of Excellence programme 2000&#x02013;2005, Sigrid Jus&#x000e9;lius Foundation, Folkh&#x000e4;lsan Research Foundation and Swedish Research Council. The Lund Stem Cell Center is supported by a Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research. Liina Lonka is a student at the Helsinki Graduate School in Biotechnology and Molecular Biology, University of Helsinki.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santavuori</surname><given-names>P</given-names></name></person-group><article-title>Neuronal ceroid-lipofuscinoses in childhood</article-title><source>Brain Dev</source><year>1988</year><volume>10</volume><fpage>80</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">3291628</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haltia</surname><given-names>M</given-names></name></person-group><article-title>The neuronal ceroid-lipofuscinoses</article-title><source>J Neuropathol Exp Neurol</source><year>2003</year><volume>62</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">12528813</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bronson</surname><given-names>RT</given-names></name><name><surname>Donahue</surname><given-names>LR</given-names></name><name><surname>Johnson</surname><given-names>KR</given-names></name><name><surname>Tanner</surname><given-names>A</given-names></name><name><surname>Lane</surname><given-names>PW</given-names></name><name><surname>Faust</surname><given-names>JR</given-names></name></person-group><article-title>Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9</article-title><source>Am J Med Genet</source><year>1998</year><volume>77</volume><fpage>289</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">9600738</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19980526)77:4&#x0003c;289::AID-AJMG8&#x0003e;3.0.CO;2-I</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranta</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ross</surname><given-names>B</given-names></name><name><surname>Lonka</surname><given-names>L</given-names></name><name><surname>Takkunen</surname><given-names>E</given-names></name><name><surname>Messer</surname><given-names>A</given-names></name><name><surname>Sharp</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>R</given-names></name><name><surname>Kusumi</surname><given-names>K</given-names></name><name><surname>Mole</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Soares</surname><given-names>MB</given-names></name><name><surname>Bonaldo</surname><given-names>MF</given-names></name><name><surname>Hirvasniemi</surname><given-names>A</given-names></name><name><surname>de la Chapelle</surname><given-names>A</given-names></name><name><surname>Gilliam</surname><given-names>TC</given-names></name><name><surname>Lehesjoki</surname><given-names>AE</given-names></name></person-group><article-title>The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8</article-title><source>Nat Genet</source><year>1999</year><volume>23</volume><fpage>233</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">10508524</pub-id><pub-id pub-id-type="doi">10.1038/13868</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Messer</surname><given-names>A</given-names></name><name><surname>Flaherty</surname><given-names>L</given-names></name></person-group><article-title>Autosomal dominance in a late-onset motor neuron disease in the mouse</article-title><source>J Neurogenet</source><year>1986</year><volume>3</volume><fpage>345</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">3783318</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Soyombo</surname><given-names>AA</given-names></name><name><surname>Atashband</surname><given-names>A</given-names></name><name><surname>Wisniewski</surname><given-names>KE</given-names></name><name><surname>Shelton</surname><given-names>JM</given-names></name><name><surname>Richardson</surname><given-names>JA</given-names></name><name><surname>Hammer</surname><given-names>RE</given-names></name><name><surname>Hofmann</surname><given-names>SL</given-names></name></person-group><article-title>Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>13566</fpage><lpage>13571</lpage><pub-id pub-id-type="pmid">11717424</pub-id><pub-id pub-id-type="doi">10.1073/pnas.251485198</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>ML</given-names></name><name><surname>Shibuya</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>PC</given-names></name><name><surname>Kaur</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>CL</given-names></name><name><surname>Johnson</surname><given-names>GS</given-names></name></person-group><article-title>A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease)</article-title><source>J Neurosci Res</source><year>1999</year><volume>57</volume><fpage>551</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">10440905</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19990815)57:4&#x0003c;551::AID-JNR15&#x0003e;3.0.CO;2-R</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchison</surname><given-names>HM</given-names></name><name><surname>Bernard</surname><given-names>DJ</given-names></name><name><surname>Greene</surname><given-names>ND</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Junaid</surname><given-names>MA</given-names></name><name><surname>Pullarkat</surname><given-names>RK</given-names></name><name><surname>de Vos</surname><given-names>N</given-names></name><name><surname>Breuning</surname><given-names>MH</given-names></name><name><surname>Owens</surname><given-names>JW</given-names></name><name><surname>Mobley</surname><given-names>WC</given-names></name><name><surname>Gardiner</surname><given-names>RM</given-names></name><name><surname>Lake</surname><given-names>BD</given-names></name><name><surname>Taschner</surname><given-names>PE</given-names></name><name><surname>Nussbaum</surname><given-names>RL</given-names></name></person-group><article-title>Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]</article-title><source>Neurobiol Dis</source><year>1999</year><volume>6</volume><fpage>321</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">10527801</pub-id><pub-id pub-id-type="doi">10.1006/nbdi.1999.0267</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cotman</surname><given-names>SL</given-names></name><name><surname>Vrbanac</surname><given-names>V</given-names></name><name><surname>Lebel</surname><given-names>LA</given-names></name><name><surname>Lee</surname><given-names>RL</given-names></name><name><surname>Johnson</surname><given-names>KA</given-names></name><name><surname>Donahue</surname><given-names>LR</given-names></name><name><surname>Teed</surname><given-names>AM</given-names></name><name><surname>Antonellis</surname><given-names>K</given-names></name><name><surname>Bronson</surname><given-names>RT</given-names></name><name><surname>Lerner</surname><given-names>TJ</given-names></name><name><surname>MacDonald</surname><given-names>ME</given-names></name></person-group><article-title>Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>2709</fpage><lpage>2721</lpage><pub-id pub-id-type="pmid">12374761</pub-id><pub-id pub-id-type="doi">10.1093/hmg/11.22.2709</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koike</surname><given-names>M</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><name><surname>Saftig</surname><given-names>P</given-names></name><name><surname>Ezaki</surname><given-names>J</given-names></name><name><surname>Isahara</surname><given-names>K</given-names></name><name><surname>Ohsawa</surname><given-names>Y</given-names></name><name><surname>Schulz-Schaeffer</surname><given-names>W</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Waguri</surname><given-names>S</given-names></name><name><surname>Kametaka</surname><given-names>S</given-names></name><name><surname>Shibata</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Kominami</surname><given-names>E</given-names></name><name><surname>Peters</surname><given-names>C</given-names></name><name><surname>von Figura</surname><given-names>K</given-names></name><name><surname>Uchiyama</surname><given-names>Y</given-names></name></person-group><article-title>Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons</article-title><source>J Neurosci</source><year>2000</year><volume>20</volume><fpage>6898</fpage><lpage>6906</lpage><pub-id pub-id-type="pmid">10995834</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lonka</surname><given-names>L</given-names></name><name><surname>Kytt&#x000e4;l&#x000e4;</surname><given-names>A</given-names></name><name><surname>Ranta</surname><given-names>S</given-names></name><name><surname>Jalanko</surname><given-names>A</given-names></name><name><surname>Lehesjoki</surname><given-names>AE</given-names></name></person-group><article-title>The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum</article-title><source>Hum Mol Genet</source><year>2000</year><volume>9</volume><fpage>1691</fpage><lpage>1697</lpage><pub-id pub-id-type="pmid">10861296</pub-id><pub-id pub-id-type="doi">10.1093/hmg/9.11.1691</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lonka</surname><given-names>L</given-names></name><name><surname>Salonen</surname><given-names>T</given-names></name><name><surname>Siintola</surname><given-names>E</given-names></name><name><surname>Kopra</surname><given-names>O</given-names></name><name><surname>Lehesjoki</surname><given-names>AE</given-names></name><name><surname>Jalanko</surname><given-names>A</given-names></name></person-group><article-title>Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells</article-title><source>J Neurosci Res</source><year>2004</year><volume>76</volume><fpage>862</fpage><lpage>871</lpage><pub-id pub-id-type="pmid">15160397</pub-id><pub-id pub-id-type="doi">10.1002/jnr.20133</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranta</surname><given-names>S</given-names></name><name><surname>Topcu</surname><given-names>M</given-names></name><name><surname>Tegelberg</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Ustubutun</surname><given-names>A</given-names></name><name><surname>Saatci</surname><given-names>I</given-names></name><name><surname>Dufke</surname><given-names>A</given-names></name><name><surname>Enders</surname><given-names>H</given-names></name><name><surname>Pohl</surname><given-names>K</given-names></name><name><surname>Alembik</surname><given-names>Y</given-names></name><name><surname>Mitchell</surname><given-names>WA</given-names></name><name><surname>Mole</surname><given-names>SE</given-names></name><name><surname>Lehesjoki</surname><given-names>AE</given-names></name></person-group><article-title>Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy</article-title><source>Hum Mutat</source><year>2004</year><volume>23</volume><fpage>300</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">15024724</pub-id><pub-id pub-id-type="doi">10.1002/humu.20018</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirvasniemi</surname><given-names>A</given-names></name><name><surname>Lang</surname><given-names>H</given-names></name><name><surname>Lehesjoki</surname><given-names>AE</given-names></name><name><surname>Leisti</surname><given-names>J</given-names></name></person-group><article-title>Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration</article-title><source>J Med Genet</source><year>1994</year><volume>31</volume><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">8014963</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Topcu</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Yalnizoglu</surname><given-names>D</given-names></name><name><surname>Usubutun</surname><given-names>A</given-names></name><name><surname>Saatci</surname><given-names>I</given-names></name><name><surname>Aynaci</surname><given-names>M</given-names></name><name><surname>Anlar</surname><given-names>B</given-names></name><name><surname>Topaloglu</surname><given-names>H</given-names></name><name><surname>Turanli</surname><given-names>G</given-names></name><name><surname>Kose</surname><given-names>G</given-names></name><name><surname>Aysun</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies</article-title><source>Turk J Pediatr</source><year>2004</year><volume>46</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">15074367</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herva</surname><given-names>R</given-names></name><name><surname>Tyynel&#x000e4;</surname><given-names>J</given-names></name><name><surname>Hirvasniemi</surname><given-names>A</given-names></name><name><surname>Syrjakallio-Ylitalo</surname><given-names>M</given-names></name><name><surname>Haltia</surname><given-names>M</given-names></name></person-group><article-title>Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis</article-title><source>Brain Pathol</source><year>2000</year><volume>10</volume><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">10764041</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Messer</surname><given-names>A</given-names></name><name><surname>Strominger</surname><given-names>NL</given-names></name><name><surname>Mazurkiewicz</surname><given-names>JE</given-names></name></person-group><article-title>Histopathology of the late-onset motor neuron degeneration (Mnd) mutant in the mouse</article-title><source>J Neurogenet</source><year>1987</year><volume>4</volume><fpage>201</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">3612378</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Messer</surname><given-names>A</given-names></name><name><surname>Plummer</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>V</given-names></name><name><surname>Lavail</surname><given-names>MM</given-names></name></person-group><article-title>Retinal degeneration in motor neuron degeneration (mnd) mutant mice</article-title><source>Exp Eye Res</source><year>1993</year><volume>57</volume><fpage>637</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">8282051</pub-id><pub-id pub-id-type="doi">10.1006/exer.1993.1169</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Messer</surname><given-names>A</given-names></name><name><surname>Plummer</surname><given-names>J</given-names></name></person-group><article-title>Accumulating autofluorescent material as a marker for early changes in the spinal cord of the Mnd mouse</article-title><source>Neuromuscul Disord</source><year>1993</year><volume>3</volume><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">8358238</pub-id><pub-id pub-id-type="doi">10.1016/0960-8966(93)90004-4</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bronson</surname><given-names>RT</given-names></name><name><surname>Lake</surname><given-names>BD</given-names></name><name><surname>Cook</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>S</given-names></name><name><surname>Davisson</surname><given-names>MT</given-names></name></person-group><article-title>Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease)</article-title><source>Ann Neurol</source><year>1993</year><volume>33</volume><fpage>381</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">7683855</pub-id><pub-id pub-id-type="doi">10.1002/ana.410330408</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Callahan</surname><given-names>LM</given-names></name><name><surname>Wylen</surname><given-names>EL</given-names></name><name><surname>Messer</surname><given-names>A</given-names></name><name><surname>Mazurkiewicz</surname><given-names>JE</given-names></name></person-group><article-title>Neurofilament distribution is altered in the Mnd (motor neuron degeneration) mouse</article-title><source>J Neuropathol Exp Neurol</source><year>1991</year><volume>50</volume><fpage>491</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">2061715</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazurkiewicz</surname><given-names>JE</given-names></name><name><surname>Callahan</surname><given-names>LM</given-names></name><name><surname>Swash</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>JE</given-names></name><name><surname>Messer</surname><given-names>A</given-names></name></person-group><article-title>Cytoplasmic inclusions in spinal neurons of the motor neuron degeneration (Mnd) mouse. I. Light microscopic analysis</article-title><source>J Neurol Sci</source><year>1993</year><volume>116</volume><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">8389815</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goddard</surname><given-names>GV</given-names></name><name><surname>McIntyre</surname><given-names>DC</given-names></name><name><surname>Leech</surname><given-names>CK</given-names></name></person-group><article-title>A permanent change in brain function resulting from daily electrical stimulation</article-title><source>Exp Neurol</source><year>1969</year><volume>25</volume><fpage>295</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">4981856</pub-id><pub-id pub-id-type="doi">10.1016/0014-4886(69)90128-9</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dennison</surname><given-names>Z</given-names></name><name><surname>Teskey</surname><given-names>GC</given-names></name><name><surname>Cain</surname><given-names>DP</given-names></name></person-group><article-title>Persistence of kindling: effect of partial kindling, retention interval, kindling site, and stimulation parameters</article-title><source>Epilepsy Res</source><year>1995</year><volume>21</volume><fpage>171</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">8536671</pub-id><pub-id pub-id-type="doi">10.1016/0920-1211(95)00025-6</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nanobashvili</surname><given-names>A</given-names></name><name><surname>Kokaia</surname><given-names>Z</given-names></name><name><surname>Lindvall</surname><given-names>O</given-names></name></person-group><article-title>Generalization of rapidly recurring seizures is suppressed in mice lacking glial cell line-derived neurotrophic factor family receptor alpha2</article-title><source>Neuroscience</source><year>2003</year><volume>118</volume><fpage>845</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">12710991</pub-id><pub-id pub-id-type="doi">10.1016/S0306-4522(02)00998-3</pub-id></citation></ref><ref id="B26"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>M</given-names></name></person-group><source>Developmental Neurobiology</source><year>1991</year><publisher-name>New York and London: Plenum Press</publisher-name></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lehtovirta</surname><given-names>M</given-names></name><name><surname>Kytt&#x000e4;l&#x000e4;</surname><given-names>A</given-names></name><name><surname>Eskelinen</surname><given-names>EL</given-names></name><name><surname>Hess</surname><given-names>M</given-names></name><name><surname>Heinonen</surname><given-names>O</given-names></name><name><surname>Jalanko</surname><given-names>A</given-names></name></person-group><article-title>Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL)</article-title><source>Hum Mol Genet</source><year>2001</year><volume>10</volume><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">11136716</pub-id><pub-id pub-id-type="doi">10.1093/hmg/10.1.69</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luiro</surname><given-names>K</given-names></name><name><surname>Kopra</surname><given-names>O</given-names></name><name><surname>Lehtovirta</surname><given-names>M</given-names></name><name><surname>Jalanko</surname><given-names>A</given-names></name></person-group><article-title>CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease</article-title><source>Hum Mol Genet</source><year>2001</year><volume>10</volume><fpage>2123</fpage><lpage>2131</lpage><pub-id pub-id-type="pmid">11590129</pub-id><pub-id pub-id-type="doi">10.1093/hmg/10.19.2123</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suopanki</surname><given-names>J</given-names></name><name><surname>Tyynel&#x000e4;</surname><given-names>J</given-names></name><name><surname>Baumann</surname><given-names>M</given-names></name><name><surname>Haltia</surname><given-names>M</given-names></name></person-group><article-title>The expression of palmitoyl-protein thioesterase is developmentally regulated in neural tissues but not in nonneural tissues</article-title><source>Mol Genet Metab</source><year>1999</year><volume>66</volume><fpage>290</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">10191117</pub-id><pub-id pub-id-type="doi">10.1006/mgme.1999.2839</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suopanki</surname><given-names>J</given-names></name><name><surname>Tyynela</surname><given-names>J</given-names></name><name><surname>Baumann</surname><given-names>M</given-names></name><name><surname>Haltia</surname><given-names>M</given-names></name></person-group><article-title>Palmitoyl-protein thioesterase, an enzyme implicated in neurodegeneration, is localized in neurons and is developmentally regulated in rat brain</article-title><source>Neurosci Lett</source><year>1999</year><volume>265</volume><fpage>53</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">10327204</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3940(99)00207-4</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isosomppi</surname><given-names>J</given-names></name><name><surname>Heinonen</surname><given-names>O</given-names></name><name><surname>Hiltunen</surname><given-names>JO</given-names></name><name><surname>Greene</surname><given-names>ND</given-names></name><name><surname>Vesa</surname><given-names>J</given-names></name><name><surname>Uusitalo</surname><given-names>A</given-names></name><name><surname>Mitchison</surname><given-names>HM</given-names></name><name><surname>Saarma</surname><given-names>M</given-names></name><name><surname>Jalanko</surname><given-names>A</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name></person-group><article-title>Developmental expression of palmitoyl protein thioesterase in normal mice</article-title><source>Brain Res Dev Brain Res</source><year>1999</year><volume>118</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">10611498</pub-id><pub-id pub-id-type="doi">10.1016/S0165-3806(99)00115-7</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tyynel&#x000e4;</surname><given-names>J</given-names></name><name><surname>Sohar</surname><given-names>I</given-names></name><name><surname>Sleat</surname><given-names>DE</given-names></name><name><surname>Gin</surname><given-names>RM</given-names></name><name><surname>Donnelly</surname><given-names>RJ</given-names></name><name><surname>Baumann</surname><given-names>M</given-names></name><name><surname>Haltia</surname><given-names>M</given-names></name><name><surname>Lobel</surname><given-names>P</given-names></name></person-group><article-title>A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration</article-title><source>Embo J</source><year>2000</year><volume>19</volume><fpage>2786</fpage><lpage>2792</lpage><pub-id pub-id-type="pmid">10856224</pub-id><pub-id pub-id-type="doi">10.1093/emboj/19.12.2786</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heinonen</surname><given-names>O</given-names></name><name><surname>Salonen</surname><given-names>T</given-names></name><name><surname>Jalanko</surname><given-names>A</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Copp</surname><given-names>A</given-names></name></person-group><article-title>CLN-1 and CLN-5, genes for infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain</article-title><source>J Comp Neurol</source><year>2000</year><volume>426</volume><fpage>406</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">10992246</pub-id><pub-id pub-id-type="doi">10.1002/1096-9861(20001023)426:3&#x0003c;406::AID-CNE5&#x0003e;3.0.CO;2-5</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hetman</surname><given-names>M</given-names></name><name><surname>Filipkowski</surname><given-names>RK</given-names></name><name><surname>Domagala</surname><given-names>W</given-names></name><name><surname>Kaczmarek</surname><given-names>L</given-names></name></person-group><article-title>Elevated cathepsin D expression in kainate-evoked rat brain neurodegeneration</article-title><source>Exp Neurol</source><year>1995</year><volume>136</volume><fpage>53</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">7589334</pub-id><pub-id pub-id-type="doi">10.1006/exnr.1995.1083</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suopanki</surname><given-names>J</given-names></name><name><surname>Lintunen</surname><given-names>M</given-names></name><name><surname>Lahtinen</surname><given-names>H</given-names></name><name><surname>Haltia</surname><given-names>M</given-names></name><name><surname>Panula</surname><given-names>P</given-names></name><name><surname>Baumann</surname><given-names>M</given-names></name><name><surname>Tyynel&#x000e4;</surname><given-names>J</given-names></name></person-group><article-title>Status epilepticus induces changes in the expression and localization of endogenous palmitoyl-protein thioesterase 1</article-title><source>Neurobiol Dis</source><year>2002</year><volume>10</volume><fpage>247</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">12270687</pub-id><pub-id pub-id-type="doi">10.1006/nbdi.2002.0503</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haltia</surname><given-names>M</given-names></name><name><surname>Herva</surname><given-names>R</given-names></name><name><surname>Suopanki</surname><given-names>J</given-names></name><name><surname>Baumann</surname><given-names>M</given-names></name><name><surname>Tyynel&#x000e4;</surname><given-names>J</given-names></name></person-group><article-title>Hippocampal lesions in the neuronal ceroid lipofuscinoses</article-title><source>Eur J Paediatr Neurol</source><year>2001</year><volume>5</volume><fpage>209</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">11588999</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mennini</surname><given-names>T</given-names></name><name><surname>Bastone</surname><given-names>A</given-names></name><name><surname>Crespi</surname><given-names>D</given-names></name><name><surname>Comoletti</surname><given-names>D</given-names></name><name><surname>Manzoni</surname><given-names>C</given-names></name></person-group><article-title>Spinal cord GLT-1 glutamate transporter and blood glutamic acid alterations in motor neuron degeneration (Mnd) mice</article-title><source>J Neurol Sci</source><year>1998</year><volume>157</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9600674</pub-id><pub-id pub-id-type="doi">10.1016/S0022-510X(98)00072-0</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mennini</surname><given-names>T</given-names></name><name><surname>Bigini</surname><given-names>P</given-names></name><name><surname>Ravizza</surname><given-names>T</given-names></name><name><surname>Vezzani</surname><given-names>A</given-names></name><name><surname>Calvaresi</surname><given-names>N</given-names></name><name><surname>Tortarolo</surname><given-names>M</given-names></name><name><surname>Bendotti</surname><given-names>C</given-names></name></person-group><article-title>Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder</article-title><source>J Neurosci Res</source><year>2002</year><volume>70</volume><fpage>553</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">12404509</pub-id><pub-id pub-id-type="doi">10.1002/jnr.10420</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Messer</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>AK</given-names></name><name><surname>Chua-Couzens</surname><given-names>J</given-names></name><name><surname>Mobley</surname><given-names>WC</given-names></name></person-group><article-title>Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment</article-title><source>J Neurosci</source><year>1999</year><volume>19</volume><fpage>2556</fpage><lpage>2567</lpage><pub-id pub-id-type="pmid">10087069</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bible</surname><given-names>E</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Hofmann</surname><given-names>SL</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name></person-group><article-title>Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis</article-title><source>Neurobiol Dis</source><year>2004</year><volume>16</volume><fpage>346</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">15193291</pub-id><pub-id pub-id-type="doi">10.1016/j.nbd.2004.02.010</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>JD</given-names></name></person-group><article-title>Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis</article-title><source>Curr Opin Neurol</source><year>2003</year><volume>16</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">12644737</pub-id><pub-id pub-id-type="doi">10.1097/00019052-200304000-00001</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>AM</given-names></name></person-group><article-title>Regulation of the mitochondrial ATP-synthase in health and disease</article-title><source>Mol Genet Metab</source><year>2003</year><volume>79</volume><fpage>71</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">12809636</pub-id><pub-id pub-id-type="doi">10.1016/S1096-7192(03)00069-6</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiltunen</surname><given-names>JO</given-names></name><name><surname>Arumae</surname><given-names>U</given-names></name><name><surname>Moshnyakov</surname><given-names>M</given-names></name><name><surname>Saarma</surname><given-names>M</given-names></name></person-group><article-title>Expression of mRNAs for neurotrophins and their receptors in developing rat heart</article-title><source>Circ Res</source><year>1996</year><volume>79</volume><fpage>930</fpage><lpage>939</lpage><pub-id pub-id-type="pmid">8888685</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kokaia</surname><given-names>Z</given-names></name><name><surname>Airaksinen</surname><given-names>MS</given-names></name><name><surname>Nanobashvili</surname><given-names>A</given-names></name><name><surname>Larsson</surname><given-names>E</given-names></name><name><surname>Kujamaki</surname><given-names>E</given-names></name><name><surname>Lindvall</surname><given-names>O</given-names></name><name><surname>Saarma</surname><given-names>M</given-names></name></person-group><article-title>GDNF family ligands and receptors are differentially regulated after brain insults in the rat</article-title><source>Eur J Neurosci</source><year>1999</year><volume>11</volume><fpage>1202</fpage><lpage>1216</lpage><pub-id pub-id-type="pmid">10103116</pub-id><pub-id pub-id-type="doi">10.1046/j.1460-9568.1999.00513.x</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauren</surname><given-names>J</given-names></name><name><surname>Airaksinen</surname><given-names>MS</given-names></name><name><surname>Saarma</surname><given-names>M</given-names></name><name><surname>Timmusk</surname><given-names>T</given-names></name></person-group><article-title>Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems</article-title><source>Mol Cell Neurosci</source><year>2003</year><volume>24</volume><fpage>581</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">14664809</pub-id><pub-id pub-id-type="doi">10.1016/S1044-7431(03)00199-4</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nanobashvili</surname><given-names>A</given-names></name><name><surname>Airaksinen</surname><given-names>MS</given-names></name><name><surname>Kokaia</surname><given-names>M</given-names></name><name><surname>Rossi</surname><given-names>J</given-names></name><name><surname>Asztely</surname><given-names>F</given-names></name><name><surname>Olofsdotter</surname><given-names>K</given-names></name><name><surname>Mohapel</surname><given-names>P</given-names></name><name><surname>Saarma</surname><given-names>M</given-names></name><name><surname>Lindvall</surname><given-names>O</given-names></name><name><surname>Kokaia</surname><given-names>Z</given-names></name></person-group><article-title>Development and persistence of kindling epilepsy are impaired in mice lacking glial cell line-derived neurotrophic factor family receptor alpha 2</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><fpage>12312</fpage><lpage>12317</lpage><pub-id pub-id-type="pmid">11050250</pub-id><pub-id pub-id-type="doi">10.1073/pnas.97.22.12312</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Racine</surname><given-names>RJ</given-names></name></person-group><article-title>Modification of seizure activity by electrical stimulation. II. Motor seizure</article-title><source>Electroencephalogr Clin Neurophysiol</source><year>1972</year><volume>32</volume><fpage>281</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">4110397</pub-id><pub-id pub-id-type="doi">10.1016/0013-4694(72)90177-0</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Northern blot and RT-PCR analysis of <italic>Cln8 </italic>mRNA expression in mouse tissues </bold><bold>A</bold>: Northern blot analysis of <italic>Cln8 </italic>transcripts in mouse tissues. A &#x003b2;-actin probe was used as a control. Molecular weight marker in kb is shown on the left. <bold>B</bold>: Real-time quantitative RT-PCR analysis of <italic>Cln8 </italic>in mouse tissues. The expression of <italic>Cln8 </italic>in brain, given a value of 1, was used as a control. The expression of <italic>Cln8 </italic>in the other tissues is shown as a fold of the control.</p></caption><graphic xlink:href="1471-2202-6-27-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold><italic>In situ </italic>hybridization analysis of <italic>Cln8 </italic>mRNA expression in mouse embryos. </bold>In the E17 mouse embryo, developing gastrointestinal tract (A, B) and DRG (C, D), hybridized with <italic>Cln8 </italic>specific cRNA probe, are shown. Bright-field view of the cells is shown on the left (A, C) and dark-field detection of hybridization signals on the right (B,D). Optical density values of hybridization signals of <italic>Cln8 </italic>sense and antisense probes in E13 and E17 gut and brain tissues are shown in the diagram (E). Error bars represent standard error of the mean. s = sense, as = antisense</p></caption><graphic xlink:href="1471-2202-6-27-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Differential distribution of <italic>Cln8 </italic>mRNA in brains of P0, P5, P10 and adult mouse. </bold>Dark-field emulsion autoradiographs from frontal sections, shown on the left, were analyzed by <italic>in situ </italic>hybridization analysis (A-D). Higher magnification in the hippocampal area CA3 is shown on the right. Bright-field views of the cells (a-d) and dark-field emulsion autoradiographs (a'-d') are shown. Optical density values of hybridization signals of <italic>Cln8 </italic>antisense probe are shown as bars in the diagram below (A = adult). Optical density values of hybridization signals of <italic>Cln8 </italic>sense probe are shown as a gray area behind the bars. In each brain region the optical density values at P0, P5 and P10 were compared to the optical density value of adult. Error bars represent standard error of the mean. Symbols *, ** and *** represent p &#x0003c; 0.05, 0.01 and 0.001, respectively. CX = cortex, DG = dentate gyrus</p></caption><graphic xlink:href="1471-2202-6-27-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Distribution of <italic>Cln8 </italic>mRNA in brains of hippocampal kindling induced epileptic mice. </bold>Frontal mouse brain sections were analyzed 2 h, 6 h and 24 h after kindling induced epileptic seizures by <italic>in situ </italic>hybridization. Mice with electrodes implanted but without electrical stimulations were used as controls (0 h). Dark-field emulsion autoradiographs of hippocampal <italic>Cln8 </italic>expression in kindling-induced mice 0 h and 24 h after kindling are shown. Optical density values of hybridization signals of <italic>Cln8 </italic>antisense probe are shown as bars in the diagram. Optical density values of hybridization signals of <italic>Cln8 </italic>sense probe are shown as a gray area behind the bars. In each brain region the optical density values 2 h, 6 h and 24 h after kidling-induced seizures were compared to controls (0 h). Error bars represent standard error of the mean. Symbols *, ** and *** represent p &#x0003c; 0.05, 0.01 and 0.001, respectively. DG = dentate gyrus</p></caption><graphic xlink:href="1471-2202-6-27-4"/></fig></sec></back></article> 